BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 21645372)

  • 1. Combined low initial DNA damage and high radiation-induced apoptosis confers clinical resistance to long-term toxicity in breast cancer patients treated with high-dose radiotherapy.
    Henríquez-Hernández LA; Carmona-Vigo R; Pinar B; Bordón E; Lloret M; Núñez MI; Rodríguez-Gallego C; Lara PC
    Radiat Oncol; 2011 Jun; 6():60. PubMed ID: 21645372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiation-induced DNA damage as a predictor of long-term toxicity in locally advanced breast cancer patients treated with high-dose hyperfractionated radical radiotherapy.
    Pinar B; Lara PC; Lloret M; Bordón E; Núñez MI; Villalobos M; Guerrero R; Luna JD; Ruiz de Almodóvar JM
    Radiat Res; 2007 Oct; 168(4):415-22. PubMed ID: 17903032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation induced apoptosis and initial DNA damage are inversely related in locally advanced breast cancer patients.
    Pinar B; Henríquez-Hernández LA; Lara PC; Bordon E; Rodriguez-Gallego C; Lloret M; Nuñez MI; De Almodovar MR
    Radiat Oncol; 2010 Sep; 5():85. PubMed ID: 20868468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of clinical toxicity in localized cervical carcinoma by radio-induced apoptosis study in peripheral blood lymphocytes (PBLs).
    Bordón E; Henríquez Hernández LA; Lara PC; Pinar B; Fontes F; Rodríguez Gallego C; Lloret M
    Radiat Oncol; 2009 Nov; 4():58. PubMed ID: 19941649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of clinical toxicity in locally advanced head and neck cancer patients by radio-induced apoptosis in peripheral blood lymphocytes (PBLs).
    Bordón E; Henríquez-Hernández LA; Lara PC; Ruíz A; Pinar B; Rodríguez-Gallego C; Lloret M
    Radiat Oncol; 2010 Jan; 5():4. PubMed ID: 20109191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Individualization of radiotherapy in breast cancer patients: possible usefulness of a DNA damage assay to measure normal cell radiosensitivity.
    Ruiz de Almodóvar JM; Guirado D; Isabel Núñez M; López E; Guerrero R; Valenzuela MT; Villalobos M; del Moral R
    Radiother Oncol; 2002 Mar; 62(3):327-33. PubMed ID: 12175564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiation-induced DNA damage and repair in lymphocytes from breast cancer patients and their correlation with acute skin reactions to radiotherapy.
    Popanda O; Ebbeler R; Twardella D; Helmbold I; Gotzes F; Schmezer P; Thielmann HW; von Fournier D; Haase W; Sautter-Bihl ML; Wenz F; Bartsch H; Chang-Claude J
    Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1216-25. PubMed ID: 12654430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro cellular radiosensitivity in relationship to late normal tissue reactions in breast cancer patients: a multi-endpoint case-control study.
    Vandevoorde C; Depuydt J; Veldeman L; De Neve W; Sebastià N; Wieme G; Baert A; De Langhe S; Philippé J; Thierens H; Vral A
    Int J Radiat Biol; 2016 Dec; 92(12):823-836. PubMed ID: 27586010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early and late skin reactions to radiotherapy for breast cancer and their correlation with radiation-induced DNA damage in lymphocytes.
    López E; Guerrero R; Núñez MI; del Moral R; Villalobos M; Martínez-Galán J; Valenzuela MT; Muñoz-Gámez JA; Oliver FJ; Martín-Oliva D; Ruiz de Almodóvar JM
    Breast Cancer Res; 2005; 7(5):R690-8. PubMed ID: 16168114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Can an extremely elevated radiosensitivity in patients be recognized by the in-vitro testing of lymphocytes?].
    Dunst J; Gebhart E; Neubauer S
    Strahlenther Onkol; 1995 Oct; 171(10):581-6. PubMed ID: 8571177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common genomic signaling among initial DNA damage and radiation-induced apoptosis in peripheral blood lymphocytes from locally advanced breast cancer patients.
    Henríquez-Hernández LA; Pinar B; Carmona-Vigo R; Bordón E; Rodríguez-Gallego C; Flores-Morales A; Lara PC
    Breast; 2013 Feb; 22(1):28-33. PubMed ID: 22687815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Constitutive gene expression profile segregates toxicity in locally advanced breast cancer patients treated with high-dose hyperfractionated radical radiotherapy.
    Henríquez Hernández LA; Lara PC; Pinar B; Bordón E; Rodríguez Gallego C; Bilbao C; Fernández Pérez L; Flores Morales A
    Radiat Oncol; 2009 Jun; 4():17. PubMed ID: 19497124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromosomal in-vitro radiosensitivity of lymphocytes in radiotherapy patients and AT-homozygotes.
    Dunst J; Neubauer S; Becker A; Gebhart E
    Strahlenther Onkol; 1998 Oct; 174(10):510-6. PubMed ID: 9810318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation-induced lymphocyte apoptosis to predict radiation therapy late toxicity in prostate cancer patients.
    Schnarr K; Boreham D; Sathya J; Julian J; Dayes IS
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1424-30. PubMed ID: 19167839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between in vitro chromosomal radiosensitivity of peripheral blood lymphocytes and the expression of normal tissue damage following radiotherapy for breast cancer.
    Barber JB; Burrill W; Spreadborough AR; Levine E; Warren C; Kiltie AE; Roberts SA; Scott D
    Radiother Oncol; 2000 May; 55(2):179-86. PubMed ID: 10799730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-response for radiation-induced apoptosis, residual 53BP1 foci and DNA-loop relaxation in human lymphocytes.
    Torudd J; Protopopova M; Sarimov R; Nygren J; Eriksson S; Marková E; Chovanec M; Selivanova G; Belyaev IY
    Int J Radiat Biol; 2005 Feb; 81(2):125-38. PubMed ID: 16019922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiosensitivity of peripheral blood lymphocytes from healthy donors and cervical cancer patients; the correspondence of in vitro data with the clinical outcome.
    Gabelova A; Farkasova T; Gurska S; Machackova Z; Lukacko P; Witkovsky V
    Neoplasma; 2008; 55(3):182-91. PubMed ID: 18348650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial.
    ; Bentzen SM; Agrawal RK; Aird EG; Barrett JM; Barrett-Lee PJ; Bliss JM; Brown J; Dewar JA; Dobbs HJ; Haviland JS; Hoskin PJ; Hopwood P; Lawton PA; Magee BJ; Mills J; Morgan DA; Owen JR; Simmons S; Sumo G; Sydenham MA; Venables K; Yarnold JR
    Lancet Oncol; 2008 Apr; 9(4):331-41. PubMed ID: 18356109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individual radiosensitivity measured with lymphocytes may predict the risk of acute reaction after radiotherapy.
    Borgmann K; Hoeller U; Nowack S; Bernhard M; Röper B; Brackrock S; Petersen C; Szymczak S; Ziegler A; Feyer P; Alberti W; Dikomey E
    Int J Radiat Oncol Biol Phys; 2008 May; 71(1):256-64. PubMed ID: 18406889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.